Journal article · 2024 · Open access
Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease
Frontiers in Neurology, 15, 1373740 · Published 30 May 2024 · DOI 10.3389/fneur.2024.1373740
In brief
“Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease” is a 2024 journal article by Lotte E. S. Hardeman and 4 co-authors, published in Frontiers in Neurology. OpenAlex counts 24 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Neurology.
- Citations
- 24
- Most cited in
- 2026 (14)
- Field-weighted impact
- 9.30
- References
- 49
- Authors
- 5
Abstract
Background Exergaming has the potential to increase adherence to exercise through play, individually tailored training, and (online) remote monitoring. Reality Digital Therapeutics (Reality DTx®) is a digital therapeutic software platform for augmented reality (AR) glasses that enables a home-based gait-and-balance exergaming intervention specifically designed for people with Parkinson’s disease (pwPD). Objective The primary objective was to evaluate the feasibility and potential efficacy of Reality DTx® AR exergaming intervention for improving gait, balance, and walking-adaptability fall-risk indicators. The secondary objective was to evaluate the potential superiority of AR glasses [Magic Leap 2 (ML2) vs. HoloLens 2 (HL2)]. Methods This waitlist-controlled clinical feasibility study comprised three laboratory visits (baseline; pre-intervention; and post-intervention), a home visit, and a 6-week AR exergaming intervention. Five complementary gait-and-balance exergames were remotely prescribed (default five sessions/week of 30 active minutes/session), monitored, and tailored. Feasibility was assessed in terms of safety, adherence, and user experience. During laboratory visits, gait-and-balance capacity was assessed using standard clinical gait-and-balance tests and advanced walking-adaptability fall-risk assessments. Results In total, 24 pwPD participated. No falls and four near falls were reported. Session adherence was 104%. The User Experience Questionnaire scores for Reality DTx® ranged from above average to excellent, with superior scores for HL2 over ML2 for Perspicuity and Dependability. Intervention effects were observed for the Timed Up and Go test (albeit small), the Five Times Sit to Stand test, and walking speed. Walking-adaptability fall-risk indicators all improved post-intervention. Conclusion Reality DTx® is a safe, adherable, usable, well-accepted, and potentially effective intervention in pwPD. These promising results warrant future randomized controlled trials on the (cost-)effectiveness of home-based AR exergaming interventions for improving gait, balance, and fall risk. Clinical trial registration ClinicalTrials.gov , identifier NCT05605249.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hardeman, L. E. S., Geerse, D. J., Hoogendoorn, E. M., Nonnekes, J. H., & Roerdink, M. (2024). Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease. Frontiers in Neurology, 15, 1373740. https://doi.org/10.3389/fneur.2024.1373740
MLA 9
Hardeman, Lotte E. S., et al. “Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease.” Frontiers in Neurology, vol. 15, 2024, p. 1373740. https://doi.org/10.3389/fneur.2024.1373740.
Chicago
Hardeman, Lotte E. S., Daphne J. Geerse, Eva M. Hoogendoorn, Jorik H. Nonnekes, and Melvyn Roerdink. 2024. “Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease.” Frontiers in Neurology 15: 1373740. https://doi.org/10.3389/fneur.2024.1373740.
Harvard
Hardeman, L. E. S. et al. (2024) ‘Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease’, Frontiers in Neurology, 15, p. 1373740. doi:10.3389/fneur.2024.1373740.
IEEE
L. E. S. Hardeman, D. J. Geerse, E. M. Hoogendoorn, J. H. Nonnekes, and M. Roerdink, “Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease,” Frontiers in Neurology, vol. 15, p. 1373740, 2024, doi: 10.3389/fneur.2024.1373740.
BibTeX
@article{hardeman2024remotely,
title = {{Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease}},
author = {Hardeman, Lotte E. S. and Geerse, Daphne J. and Hoogendoorn, Eva M. and Nonnekes, Jorik H. and Roerdink, Melvyn},
journal = {Frontiers in Neurology},
year = {2024},
volume = {15},
pages = {1373740},
doi = {10.3389/fneur.2024.1373740},
url = {https://doi.org/10.3389/fneur.2024.1373740}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 1 | |
| 2025 | 9 | |
| 2026 | 14 |
Its field-weighted citation impact is 9.30: it has been cited 9.30 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Balance, Gait, and Falls Prevention
- Parkinson's disease
- augmented reality glasses
- exergames
- gait
- balance
- fall risk
- home-based exercise
- digital therapeutics
Work with this paper
Most-cited papers in Health Professions
- DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTIONAllan Godfrey Gornall, Charles J. Bardawill, Maxima M. David · Journal of Biological Chemistry · 1949 · 16,172 citations
- Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation scienceLaura J. Damschroder, David Clark Aron, Rosalind E. Keith and 3 more · Implementation Science · 2009 · 15,527 citations
- FUNCTIONAL EVALUATION: THE BARTHEL INDEX.FLORENCE I. MAHONEY, DOROTHEA W. BARTHEL · PubMed · 1965 · 15,488 citations
- The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly PersonsDiane Podsiadlo, Sandra Richardson · Journal of the American Geriatrics Society · 1991 · 15,001 citations
- National Committee for Clinical Laboratory StandardsErika Bruck · PEDIATRICS · 1980 · 14,735 citations
Questions about this paper
How do I cite this paper in APA style?
Hardeman, L. E. S., Geerse, D. J., Hoogendoorn, E. M., Nonnekes, J. H., & Roerdink, M. (2024). Remotely prescribed, monitored, and tailored home-based gait-and-balance exergaming using augmented reality glasses: a clinical feasibility study in people with Parkinson’s disease. Frontiers in Neurology, 15, 1373740. https://doi.org/10.3389/fneur.2024.1373740
How many times has this paper been cited?
24 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Frontiers in Neurology: sign in and open the PDF from this page.
Who wrote this paper?
Lotte E. S. Hardeman, Daphne J. Geerse, Eva M. Hoogendoorn, Jorik H. Nonnekes, Melvyn Roerdink.
What is the DOI of this paper?
10.3389/fneur.2024.1373740, permanently at https://doi.org/10.3389/fneur.2024.1373740. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.